Charter Communications Posts Upbeat Earnings, Joins Atlassian, SkyWest, Eastman Chemical, AbbVie And Other Big Stocks Moving Higher On Friday

U.S. stocks were higher, with the Nasdaq Composite gaining more than 1% on Friday.

Shares of Charter Communications, Inc. CHTR rose during Friday's session after the company reported better-than-expected fourth-quarter financial results.

Charter Communications reported fiscal fourth-quarter 2024 revenue growth of 1.6% year-on-year to $13.93 billion, beating the analyst consensus estimate of $13.88 billion. EPS of $10.10 beat the analyst consensus estimate of $9.22.

Charter Communications shares jumped 5.4% to $354.63 on Friday.

Here are some other big stocks recording gains in today's session.

Viavi Solutions Inc. VIAV shares jumped 26% to $12.58 after the company reported better-than-expected second-quarter financial results.
Diginex Limited DGNX gained 22% to $42.60.
Cipher Mining Inc. CIFR shares rose 21.8% to $5.73 after the company announced a $50 million investment from Softbank.
Atlassian Corporation TEAM gained 17.7% to $314.07 as the company reported better-than-expected financial results for the fiscal second quarter after the market close on Thursday.
SkyWest, Inc. SKYW gained 15.3% to $134.63 following strong quarterly earnings.
Celestica Inc. CLS rose 15.3% to $131.62. The company recently posted better-than-expected fourth-quarter financial results.
AST SpaceMobile, Inc. ASTS rose 14.6% to $20.87 after the company announced the FCC granted the company Special Temporary Authority, authorizing testing service in the U.S.
Credo Technology Group Holding Ltd CRDO surged 13% to $72.93.
RBC Bearings Incorporated RBC rose 12.1% to $360.84 following upbeat earnings.
Redwire Corporation RDW gained 10.1% to $25.06.
JetBlue Airways Corporation JBLU rose 9% to $6.89.
Mobileye Global Inc. MBLY gained 8.5% to $17.69.
Eastman Chemical Company EMN surged 7.7% to $99.84 after the company reported better-than-expected quarterly adjusted EPS results.
AbbVie Inc. ABBV gained 7.4% to $188.60. The company reported fourth-quarter adjusted earnings per share of $2.16, beating the street view of $2.11.
Vertex Pharmaceuticals Incorporated VRTX rose 5.8% to $463.83 after the company announced it secured FDA approval for JOURNAVX. Also, the company announced a reimbursement agreement with NHS England for eligible sickle cell disease patients to access CASGEVY.
Baker Hughes Company BKR gained 4.6% to $46.68 following upbeat earnings.